Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Albireo Pharma Inc (ALBO) Stock Forecast 2025 - AI Price Prediction & Analysis

Albireo Pharma Inc (ALBO) AI Stock Price Forecast & Investment Analysis

Albireo Pharma Inc Stock Price Chart and Technical Analysis

Loading Albireo Pharma Inc interactive price chart and technical analysis...

Albireo Pharma Inc (ALBO) - Comprehensive Stock Analysis & Investment Research

Deep dive into Albireo Pharma Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Albireo Pharma Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Albireo Pharma Inc: Albireo Pharma Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Albireo Pharma Inc (Stock Symbol: ALBO) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 130 professionals worldwide and operates under the strategic leadership of CEO Ronald Cooper.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Albireo Pharma Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Albireo Pharma Inc: With $13M in annual revenue and -359.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $13 million generating a -359.5% net profit margin .

Market Capitalization: $914 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -22.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Albireo Pharma Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Albireo Pharma Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Albireo Pharma Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Albireo Pharma Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Albireo Pharma Inc: Market positioning analysis based on available financial and operational metrics.

Albireo Pharma Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 20.0% gross margin, indicating strong pricing power and operational efficiency.

Albireo Pharma Inc (ALBO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Albireo Pharma Inc stock analysis.

Loading Albireo Pharma Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Albireo Pharma Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Albireo Pharma Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Albireo Pharma Inc: With a P/E ratio of -6.36, the market sees the stock as potentially undervalued.

P/E Ratio -6.36x
P/B Ratio 9.13x
Market Cap $914M
EPS $-6.72
Book Value/Share $4.84
Revenue/Share $2.77
FCF/Share $-5.93
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Albireo Pharma Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Albireo Pharma Inc: An ROE of -22.1% indicates room for improvement in shareholder value creation.

ROE -22.1%
ROA -12.8%
ROIC -12.6%
Gross Margin 20.0%
Operating Margin -906.1%
Net Margin -359.5%
EBT Margin -72.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Albireo Pharma Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Albireo Pharma Inc: A current ratio of 7.26 indicates strong liquidity.

Current Ratio 7.26x
Quick Ratio 6.92x
D/E Ratio 0.07x
Financial Leverage 1.76x
Interest Coverage -1.6x
Working Capital $237M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Albireo Pharma Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Albireo Pharma Inc: Free cash flow of $-109M indicates cash challenges that need attention.

Operating Cash Flow $-108M
Free Cash Flow $-109M
FCF/Sales -239.7%
CapEx/Sales 1.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Albireo Pharma Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Albireo Pharma Inc: An asset turnover of 0.18x suggests room for improvement in asset utilization.

Asset Turnover 0.18x
Receivables Turnover 35.6x
Inventory Turnover 0.9x
Fixed Assets Turnover 71.2x
Days Sales Outstanding 10 days
Days Inventory 418 days
Payables Period 1486 days
Cash Conversion Cycle -1058 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Albireo Pharma Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Albireo Pharma Inc: With annual revenue of $13M, Albireo Pharma Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $13M
Operating Income $-122M
Net Income $-48M
R&D Expense $89M
SG&A Expense $157M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 88%
Cash & Short-term Investments 83%
Total Liabilities 43%
Short-term Debt 1%
Accounts Receivable 0%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 21M
Growth Metrics (YoY)
EPS Growth -15.2%

Latest Albireo Pharma Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Albireo Pharma Inc (ALBO) stock price and investment outlook.

, source: The Motley Fool

I will now turn the call over to your host, Paul Arndt, Managing Director of LifeSci Advisors. Thank you. You may begin. Paul Arndt-- Investor Relations and Corporate Communications Eexecutive Thank ...

Albireo Pharma Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Albireo Pharma Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Albireo Pharma Inc Stock Forecast

How accurate are Albireo Pharma Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for ALBO predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Albireo Pharma Inc stock price forecasts?

Our analysis considers Albireo Pharma Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Albireo Pharma Inc a good investment in 2025?

Based on our AI analysis, Albireo Pharma Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Albireo Pharma Inc forecasts updated?

Albireo Pharma Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Albireo Pharma Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Albireo Pharma Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...